$3.93
At close: Sep 19, 8:00 AM EDT
$0.3310
-3.60-91.58%
After Hours: Sep 19, 8:00 AM EDT
Comments
Loading...
NexImmune Analyst Ratings and Price Targets | OTC:NEXI | Benzinga
NexImmune Inc has a consensus price target of $3.5 based on the ratings of 4 analysts. The high is $5 issued by BTIG on June 1, 2022. The low is $2 issued by Barclays on August 16, 2022. The 3 most-recent analyst ratings were released by Barclays, Raymond James, and BTIG on August 16, 2022, August 16, 2022, and June 1, 2022, respectively. With an average price target of $3.33 between Barclays, Raymond James, and BTIG, there's an implied 907.20% upside for NexImmune Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
BTIG
1calculated from analyst ratings
Analyst Ratings for NexImmune
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/16/2022 | Buy Now | — | Cantor Fitzgerald | Alethia Young76% | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/15/2022 | Buy Now | — | Raymond James | Steven Seedhouse58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/16/2022 | Buy Now | 504.32% | Barclays | Peter Lawson41% | $175 → $50 | Maintains | Overweight | Get Alert |
| 08/16/2022 | Buy Now | 806.48% | Raymond James | Steven Seedhouse58% | $300 → $75 | Maintains | Outperform | Get Alert |
| 06/01/2022 | Buy Now | 1410.8% | BTIG | Kaveri Pohlman25% | → $125 | Initiates | → Buy | Get Alert |
| 04/01/2022 | Buy Now | 2015.12% | Barclays | Peter Lawson41% | $100 → $175 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for NexImmune (NEXI) stock?
The latest price target for NexImmune (OTCEM:NEXI) was reported by Cantor Fitzgerald on November 16, 2022. The analyst firm set a price target for $0.00 expecting NEXI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NexImmune (NEXI)?
The latest analyst rating for NexImmune (OTCEM:NEXI) was provided by Cantor Fitzgerald, and NexImmune downgraded their neutral rating.
When was the last upgrade for NexImmune (NEXI)?
There is no last upgrade for NexImmune
When was the last downgrade for NexImmune (NEXI)?
The last downgrade for NexImmune Inc happened on November 16, 2022 when Cantor Fitzgerald changed their price target from N/A to N/A for NexImmune Inc.
When is the next analyst rating going to be posted or updated for NexImmune (NEXI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NexImmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NexImmune was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
Is the Analyst Rating NexImmune (NEXI) correct?
While ratings are subjective and will change, the latest NexImmune (NEXI) rating was a downgraded with a price target of $0.00 to $0.00. The current price NexImmune (NEXI) is trading at is $0.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.